The Times reports on Chelsea and Westminster Hospital NHS Foundation Trust deploying DERM autonomously, marking a new era for cancer care.
In Saturday’s paper, The Times published an article on our partnership with Chelsea and Westminster Hospital NHS Foundation Trust (CWFT), detailing how they’re ‘pioneering the use of artificial intelligence to diagnose skin cancer, enabling patients to get lifesaving checks for the disease without seeing a doctor.’
Eleanor Hayward, Health Editor at The Times, goes on to say:
‘It is the first AI technology in the world to be approved to make clinical decisions on cancer treatment autonomously, without requiring a doctor to double-check its findings.’
‘Nearly half of patients get the all clear and are automatically discharged with no further appointments, while those with cancer or who need further investigation are booked in to see a specialist doctor and begin treatment.’
Listen to Consultant Dermatologist, Dr Lucy Thomas on Radio 4
Consultant Dermatologist at Chelsea and Westminster Hospital NHS Foundation Trust, Dr Lucy Thomas, interviews on Radio 4 talking about the autonomous deployment of DERM for AI skin cancer checks.
Coverage starts at 20.57.